Assessment of Clinical Profile and Treatment Outcome in Vaccinated and Unvaccinated SARS-CoV-2 Infected Patients

Vaccines against severe acute respiratory syndrome-corona virus-2 (SARS-CoV-2) infection, which causes coronavirus disease–19 (COVID-19) in humans, have been developed and are being tested for safety and efficacy. We conducted the cross-sectional prospective cohort study on 820 patients who were pos...

Descripción completa

Detalles Bibliográficos
Autores principales: Korishettar, Ganesh, Chikkahonnaiah, Prashanth, Tulimilli, SubbaRao V., Dallavalasa, Siva, Byrappa, Shashidhar H., Madhunapantula, SubbaRao V., Veeranna, Ravindra P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321523/
https://www.ncbi.nlm.nih.gov/pubmed/35891289
http://dx.doi.org/10.3390/vaccines10071125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321523/
https://www.ncbi.nlm.nih.gov/pubmed/35891289
http://dx.doi.org/10.3390/vaccines10071125

Ejemplares similares